CD44 is a surface glycoprotein important in tumor initiation, and metastasis is used as a cancer stem cell biomarker.[23] CD133 is a cancer stem cell (CSC) biomarker in lung tumors,[24] while CD166 promotes cancer stem‐likeness in primary cancer cells.[25]. This evidence concerns the gene CD44 and neoplasm.